Policy Notices

• Reminder: NIH Policy on Use of Hypertext in NIH Grant Applications
  (NOT-OD-20-174)
  National Institutes of Health
  

General Notices

• Notice of Expiration of PA-17-247 - Implementation and Evaluation of New Health Information Technology (IT) Strategies for Collecting and Using Patient-Reported Outcome (PRO) Measures (U18)
  (NOT-HS-20-016)
  Agency for Healthcare Research and Quality
  

• Notice of Application Form Issue with PAR-18-812 Occupational Safety and Health Research (R01)
  (NOT-OH-20-009)
  National Institute for Occupational Safety and Health
  

• Notice of Application Form Issue with PAR-18-799 NIOSH Mentored Research Scientist Development Award (K01)
  (NOT-OH-20-010)
  National Institute for Occupational Safety and Health
  

• Notice of Application Form Issue with PAR-18-798 Occupational Safety and Health Research (R21)
  (NOT-OH-20-011)
  National Institute for Occupational Safety and Health
  

• Notice of Application Form Issue with PAR-18-797 NIOSH Small Research Grant Program (R03)
  (NOT-OH-20-012)
  National Institute for Occupational Safety and Health
  

• Update for RFA-OH-21-003 "Extension of the World Trade Center Health Registry (U50)"
  (NOT-OH-21-001)
  National Institute for Occupational Safety and Health
  

• Update for RFA-OH-21-004 "Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)"
  (NOT-OH-21-002)
  National Institute for Occupational Safety and Health
  

• Update for PAR-20-280 "Cooperative Research Agreements Related to the World Trade Center Health Program (U01)"
  (NOT-OH-21-003)
  National Institute for Occupational Safety and Health
  

• Pre-Application Webinar for RFA-TR-20-030, Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed)
  (NOT-TR-20-037)
  National Center for Advancing Translational Sciences
  

• Request for Information: Response to Proposed NIH Rehabilitation Research Plan Objectives
  (NOT-HD-20-033)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Request for Information: Ambitious Collaborative Goals for Bioelectronic Medicine
  (NOT-RM-20-025)
  Office of Strategic Coordination (Common Fund)
  

Notice of Changes to Funding Opportunities

• Notice of Change to RFA-AG-21-016 "Planning Projects for Clinical Trials on Effects of Sustained Reductions in Caloric Intake and Related Dietary Practices in Younger and Older Persons (U01 Clinical Trial Optional)"
  (NOT-AG-20-050)
  National Institute on Aging
  

• Notice of Extension of the Expiration Date for PAR-18-336 NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trial Required)
  (NOT-CA-20-099)
  National Cancer Institute
  

• Clarification of the Role of the Intramural Investigator in PAR-18-950 and PAR-18-951 Opportunities for Collaborative Research at the NIH Clinical Center (X02 and U01)
  (NOT-HD-20-029)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  

• Notice of Change to Key Dates for RFA-NS-18-019 "BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)"
  (NOT-NS-20-108)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change to Key Dates for RFA-NS-18-020 "BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)"
  (NOT-NS-20-109)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change: Expansion of Research Scope of RFA-OD-19-029 The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)"
  (NOT-OD-20-168)
  Office of Research on Women's Health
  

• Notice of Change to Key Dates for RFA-OH-20-001 Miner Safety and Health Training Program - Western United States (U60)
  (NOT-OH-20-013)
  National Institute for Occupational Safety and Health
  

Notices of Special Interest

• Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)
  (NOT-HL-20-814)
  National Heart, Lung, and Blood Institute
  

Funding Opportunities

• NIAID Research Education Program (R25 Clinical Trial Not Allowed)
  (PAR-20-289)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): December 7, 2020; May 25, 2021; and May 25, 2022
  
  

• Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03 Clinical Trial Not Allowed)
  (PAR-20-290)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is October 16, 2020.
  
  

• Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed)
  (PAR-20-291)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is October 16, 2020.
  
  

• Drug Development Collaboratory (UG3/UH3 Clinical Trial Required)
  (PAR-20-301)
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): February 9, 2021; June 9, 2021; February 9, 2022; June 9, 2022; February 9, 2023; June 9, 2023
  
  

• Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
  (PAR-20-304)
  National Library of Medicine
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is February 5, 2021.
  
  

• Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed)
  (RFA-CA-20-043)
  National Cancer Institute
  Application Receipt Date(s): January 20, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
  
  

• Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)
  (RFA-CA-20-051)
  National Cancer Institute
  Office of Disease Prevention
  Application Receipt Date(s): March 15, 2021; January 18, 2022 No late applications will be accepted for this Funding Opportunity Announcement.
  
  

• HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Clinical Centers (U01 Clinical Trial Not Allowed)
  (RFA-HL-21-015)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): December 7, 2020
  
  

• HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Data Translation Center (U54 Clinical Trial Not Allowed)
  (RFA-HL-21-016)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): December 7, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• BRAIN Initiative: Pilot resources for brain cell type-specific access and manipulation across vertebrate species (U01 Clinical Trial Not Allowed)
  (RFA-MH-20-556)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): February 11, 2021; October 19, 2021, by 5:00 PM local time of applicant organization.
  
  

• HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
  (RFA-NS-21-010)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  Office of Research on Women's Health
  Application Receipt Date(s): November 18, 2020, March 24, 2021, July 14, 2021, October 15, 2021, February 15, 2022, June 15, 2022, by 5:00PM local time of applicant organization. Alltypes of non-AIDS applicationsallowed for this funding opportunity announcement are due on these dates.
  
  

• Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (UG3/UH3 Clinical Trial Required)
  (RFA-TR-20-031)
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): November 12, 2020
  
  

• Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)
  (RFA-TR-20-032)
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): November 12, 2020